Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000899243-21-010811

Options or other derivatives

  • Chief Financial Officer acquired 55,294 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pizzie Nick Chief Financial Officer 2021-03-05 Grant or award · Employee Stock Option (Right to Buy) +36,086 36,086 D
Pizzie Nick Chief Financial Officer 2021-03-05 Grant or award · Restricted Stock Units +19,208 19,208 D
Loading xslF345X03/doc4.xml…